期刊文献+

吡格列酮保护缺氧复氧诱导乳鼠心肌细胞凋亡的离子通道机制

Ion channel mechanism of cardioprotection of pioglitazone against hypoxia-reoxygenation induced apoptosis
下载PDF
导出
摘要 目的观察吡格列酮对缺氧复氧大鼠心肌细胞凋亡的保护作用,并探讨保护作用与ATP敏感性钾通道开放的关系。方法原代培养的SD乳鼠心肌细胞,分为8组:溶媒组、缺氧复氧组、0.1μmol/L吡格列酮组、1 μmol/L吡格列酮组、2μmol/L吡格列酮组、2μmol/L吡格列酮+30μmol/L HMR-1098组、2μmol/L吡格列酮+0.5mmol/L 5-羟基葵酸盐(5-HD)组、2μmol/L吡格列酮+30μmol/L HMR-1098+0.5 mmol/L 5-HD组。利用膜联蛋白-V与碘化丙啶双染法及Hoechst 33258染色法检测心肌细胞凋亡。结果缺氧复氧组乳鼠心肌细胞发生明显凋亡,经吡格列酮预处理后减少心肌细胞凋亡(P<0.05);与0.1μmol/L、1μmol/L及2μmol/L吡格列酮组比较,5-HD削弱吡格列酮抑制心肌细胞凋亡的作用(P<0.05),HMR-1098无作用(P>0.05)。结论吡格列酮对缺氧复氧乳鼠心肌细胞凋亡具有保护作用,线粒体ATP敏感性钾通道的开放可能介导了吡格列酮的保护作用。 Objective To investigate the protective effect of pioglitazone against the hypoxia-reoxygenation induced cardiac myocytes apoptosis and the role of ATP-sensitive potassium channel in the cardioprotection of pioglitazone. Methods Primary cultured cardiomyocytes of neonatal Sprague- Dawley rats were divided into 8 groups:vehicle, hypoxia-reoxygenation, 0.1μmol/L pioglitazone, 1μmol/L pioglitazone, 2μmol/L pioglitazone, 2μmol/L pioglitazone + HMR-1098, 2 μmol/L pioglitazone + 5-hydroxy decanoate (5-HD), 2μmol/L pioglitazone + HMR-1098 + 5-HD. The cells were stained with Annexin-V FITC/PI and Hoechst-33258 which was used to detect the apoptosis of cardiomyocytes. Results Apoptosis index in hypoxia-reoxygenation group significantly increased compared with the vehicle group (P〈0.05). Pioglitazone decreased apoptosis index in dose-dependent manner. 5-HD attenuated the protective effect of 2.0μmol/L pioglitazone against apoptosis (P〈0.05) and HMR-1098 had no effect on the protection. Conclusions Pretreatment with pioglitazone can reduce cardiomyocyte apoptosis induced by hypoxia-reoxygenation. Pioglitazone may exert cardioprotection against apoptosis via opening mitoKATP channel and not via sarcKATP channel.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2009年第5期362-364,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 缺氧 心肌 细胞凋亡 离子通道 过氧化物酶体增殖物激活受体 线粒体 anoxia myocardium apoptosis ion channels peroxisome proliferator activated receptors mitochondria
  • 相关文献

参考文献8

  • 1Cao ZL,Ye P, Long CL, et al. Effect of pioglitazone, a peroxisome proliferator-activated receptor 7 agonist, on ischemia reperfusion injury in rats. Pharmacology, 2007,79 : 184-192.
  • 2Testai L, Rapposelli S,Calderone V. Cardiac ATP-sensitive potassium channels:a potential target for an anti-ischaemic pharmacological strategy. Cardiovasc Hematol Agents Med Chem, 2007,5 : 79-90.
  • 3Pi Y,Goldenthal MJ, Marin-Garcia J. Mitochondrial involvement in IGF-1 induced protection of eardiomyocytes against hypoxia/ reoxygenation injury. Mol Cell Biochem, 2007,301 1:181-189.
  • 4王浩,叶平,李宗斌,李泱,曹泽玲,王琳.吡格列酮保护大鼠心肌缺血再灌注损伤机制的研究[J].中华老年心脑血管病杂志,2008,10(7):537-540. 被引量:2
  • 5曹泽玲,叶平,龙超良,陈凯,李小卫,汪海.吡格列酮对缺血再灌注心肌细胞凋亡影响的实验研究[J].中华心血管病杂志,2005,33(7):648-652. 被引量:23
  • 6Honda HM, Korge P, Weiss JN. Mitochondria and ischemia/ reperfusion injury. Ann N Y Acad Sci,2005,1047:248-258.
  • 7Zaugg M, Schaub MC. Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning. J Muscle Res Cell Motil, 2003,24 : 219-249.
  • 8Li J, Lang MJ, Mao XB, et al. Antiapoptosis and mitoehondrial effect of pioglitazone preconditioning in the ischemic/reperfused heart of rat. Cardiovasc Drugs Ther, 2008,22 : 283-291.

二级参考文献32

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部